230 related articles for article (PubMed ID: 17219217)
21. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
Kuypers KP; Samyn N; Ramaekers JG
Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
[TBL] [Abstract][Full Text] [Related]
22. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
Glue P; Fang A; Gandelman K; Klee B
Am J Ther; 2006; 13(5):418-22. PubMed ID: 16988537
[TBL] [Abstract][Full Text] [Related]
24. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
25. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.
Allen D; Curran HV; Lader M
Eur J Clin Pharmacol; 1991; 40(4):355-62. PubMed ID: 2050170
[TBL] [Abstract][Full Text] [Related]
26. [The cognitive effect of alprazolam in healthy volunteers].
Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
[TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Verster JC; Volkerts ER
CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
[TBL] [Abstract][Full Text] [Related]
28. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
[TBL] [Abstract][Full Text] [Related]
29. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Klein E
J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
[TBL] [Abstract][Full Text] [Related]
30. Evaluating drugged driving: Effects of exemplar pain and anxiety medications.
Brown TL; Milavetz G; Gaffney G; Spurgin A
Traffic Inj Prev; 2018 Feb; 19(sup1):S97-S103. PubMed ID: 29584496
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol.
Huizinga CR; Zuiker RG; de Kam ML; Ziagkos D; Kuipers J; Mejia Y; van Gerven JM; Cohen AF
J Psychopharmacol; 2019 Jul; 33(7):791-800. PubMed ID: 30912701
[TBL] [Abstract][Full Text] [Related]
32. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood.
Verster JC; Veldhuijzen DS; Volkerts ER
Clin J Pain; 2006 Jun; 22(5):499-504. PubMed ID: 16772806
[TBL] [Abstract][Full Text] [Related]
33. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo.
Theunissen EL; Vermeeren A; van Oers AC; van Maris I; Ramaekers JG
Clin Exp Allergy; 2004 Feb; 34(2):250-8. PubMed ID: 14987305
[TBL] [Abstract][Full Text] [Related]
34. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.
Vermeeren A; O'Hanlon JF
J Allergy Clin Immunol; 1998 Mar; 101(3):306-11. PubMed ID: 9525444
[TBL] [Abstract][Full Text] [Related]
35. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
[TBL] [Abstract][Full Text] [Related]
36. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.
van Laar MW; van Willigenburg AP; Volkerts ER
J Clin Psychopharmacol; 1995 Feb; 15(1):30-40. PubMed ID: 7714226
[TBL] [Abstract][Full Text] [Related]
37. A process-based approach to characterizing the effect of acute alprazolam challenge on visual paired associate learning and memory in healthy older adults.
Pietrzak RH; Scott JC; Harel BT; Lim YY; Snyder PJ; Maruff P
Hum Psychopharmacol; 2012 Nov; 27(6):549-58. PubMed ID: 23027677
[TBL] [Abstract][Full Text] [Related]
38. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
Leufkens TR; Vermeeren A
Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
[TBL] [Abstract][Full Text] [Related]
39. The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers.
Takahashi M; Iwamoto K; Kawamura Y; Nakamura Y; Ishihara R; Uchiyama Y; Ebe K; Noda A; Noda Y; Yoshida K; Iidaka T; Ozaki N
Hum Psychopharmacol; 2010 Apr; 25(3):260-7. PubMed ID: 20373478
[TBL] [Abstract][Full Text] [Related]
40. Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
Linnoila M; Stapleton JM; Lister R; Moss H; Lane E; Granger A; Eckardt MJ
Eur J Clin Pharmacol; 1990; 39(1):21-8. PubMed ID: 2276384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
